OpenVSafe by OpenVAERS
Search V-safe

DZ2-29359-41358

2 vaccinations 11 coded responses 25 check-ins 11 free-text entries 2 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
220 / VA
Registered
2021-01-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-22
    Registered in v-safe
  2. 2021-01-22
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-22
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  6. 2021-01-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  8. 2021-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-29
    Survey response — day 7, dose 1
    MedDRA: Nasal congestion, Sneezing — Feeling: Fair · Site: Itching
    Free text: Sneezing and nasal congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-05
    Survey response — day 14, dose 1
    MedDRA: Injection site pruritus — Feeling: Good
    Free text: More frequent itching at injection site without skin changes.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-12
    Dose 2 — Pfizer-BioNTech
  13. 2021-02-12
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Joint pains, Muscle or body aches
    Adult check-in
  14. 2021-02-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches
    Adult check-in
  15. 2021-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  16. 2021-02-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Nasal congestion, Rhinorrhoea, Sneezing — Feeling: Poor · Site: Pain · Headache, Joint pains · Be unable to do your normal daily activities
    Free text: Nasal congestion, sneezing, runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Nasal congestion — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Free text: Nasal congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Nasal congestion, Sneezing — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: Nasal congestion, sneezing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-02-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Nasal congestion — Feeling: Good
    Free text: Mild nasal congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-02-19
    Survey response — day 7, dose 2
    MedDRA: Nasal congestion — Feeling: Good
    Free text: Mild nasal congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-02-26
    Survey response — day 14, dose 2
    MedDRA: Antiallergic therapy, Malaise, Nasal congestion, Rhinorrhoea, Self-medication — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Significantly ill on 21 Feb 2021 with severe nasal congestion and constant clear rhinorrhea not significantly relieved with antihistamines or OTC cold medicines. Stayed in bed all day and most of next day, not improved until 24 Feb, then relapsed.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-03-05
    Survey response — day 21, dose 2
    MedDRA: Head discomfort, Headache, Loss of personal independence in daily activities, Nasal congestion, Paranasal sinus discomfort, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activities
    Free text: Still having episodes of significant nasal congestion and rhinorrhea that impact daily activities and require medication. Awoke with a headache this morning, with persistent pressure in head and sinuses.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-03-12
    Survey response — day 28, dose 2
    MedDRA: Nasal congestion, Rhinorrhoea, Self-medication, Sneezing — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Severe nasal congestion, sneezing, and runny nose not responding well to OTC medications or antibiotics. Unclear if underlying ENT/sinus issue, immunology issue, or due to CPAP machine.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-03-12
    Report sent to call center — day 28, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-03-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-03-26
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-05-14
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-08-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2022-02-12
    Survey response — 12 months, dose 2
    MedDRA: Chills, Cough, Fatigue, Nasal disorder, Pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Fever, chills, cough, nasal symptoms, body aches, fatigue, lasting several days, with residual cough and fatigue lasting another week.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-02-12
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  31. 2022-02-15

Vaccinations

DoseDateManufacturerCo-administered
12021-01-22Pfizer-BioNTech
22021-02-12Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 3 — day 7, dose 1

2021-01-29

Systemic reaction (other): Sneezing and nasal congestion

Release 3 — day 14, dose 1

2021-02-05

Symptoms: More frequent itching at injection site without skin changes.

Release 4 — days 1–6 daily, dose 2

2021-02-15

Systemic reaction (other): Nasal congestion, sneezing, runny nose

2021-02-16

Systemic reaction (other): Nasal congestion

2021-02-17

Systemic reaction (other): Nasal congestion, sneezing

2021-02-18

Systemic reaction (other): Mild nasal congestion

Release 4 — day 7, dose 2

2021-02-19

Systemic reaction (other): Mild nasal congestion

Release 4 — day 14, dose 2

2021-02-26

Symptoms: Significantly ill on 21 Feb 2021 with severe nasal congestion and constant clear rhinorrhea not significantly relieved with antihistamines or OTC cold medicines. Stayed in bed all day and most of next day, not improved until 24 Feb, then relapsed. cut off by CDC

Release 5 — day 21, dose 2

2021-03-05

Symptoms: Still having episodes of significant nasal congestion and rhinorrhea that impact daily activities and require medication. Awoke with a headache this morning, with persistent pressure in head and sinuses.

Release 5 — day 28, dose 2

2021-03-12

Symptoms: Severe nasal congestion, sneezing, and runny nose not responding well to OTC medications or antibiotics. Unclear if underlying ENT/sinus issue, immunology issue, or due to CPAP machine.

Release 11 — 12 months, dose 2

2022-02-12

Symptoms: Fever, chills, cough, nasal symptoms, body aches, fatigue, lasting several days, with residual cough and fatigue lasting another week.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAntiallergic therapy ✓ ✓ ○
SDChills · · ✓
SDCough · · ✓
SDFatigue · · ✓
SDHead discomfort ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDInjection site pruritus ✓ ✓ ✓
SDLoss of personal independence in daily activities ✓ ✓ ✓
SDMalaise · · ✓
SDNasal congestion ✓ ✓ ✓
SDNasal disorder · · ✓
SDPain · · ✓
SDParanasal sinus discomfort ✓ ✓ ✓
SDPyrexia · · ✓
SDRhinorrhoea ✓ ✓ ✓
SDSelf-medication ✓ ✓ ✓
SDSneezing ✓ ✓ ✓
SRONasal congestion ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓
SROSneezing ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release